Some Ebola Patients Should Get Placebo in Drug Tests: FDA

Some Ebola patients need to forgo potentially life-saving treatments so researchers can see how they fare compared to people who get the experimental drugs, a Food and Drug Administration official said today.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.